Format

Send to:

Choose Destination
See comment in PubMed Commons below
Vet J. 2014 Jan;199(1):39-43. doi: 10.1016/j.tvjl.2013.10.024. Epub 2013 Oct 29.

The effect of a spot-on formulation containing polyunsaturated fatty acids and essential oils on dogs with atopic dermatitis.

Author information

  • 1Clinic of Small Animal Medicine at the Centre for Clinical Veterinary Medicine, Ludwig-Maximilian University, Veterinärstrasse 13, 80539 Munich, Germany.
  • 2Animal Dermatology Clinic, Tustin, CA 92780, USA.
  • 3Derm4Pets Clinic, Chiltern Referral Services, Chalfont St. Giles, Buckinghamshire HP8 4AB, UK.
  • 4Clinics for Ruminants at the Centre for Clinical Veterinary Medicine, Ludwig-Maximilians University, Sonnenstrasse 16, 85764 Oberschleissheim, Germany.
  • 5Clinic of Small Animal Medicine at the Centre for Clinical Veterinary Medicine, Ludwig-Maximilian University, Veterinärstrasse 13, 80539 Munich, Germany. Electronic address: R.Mueller@lmu.de.

Abstract

Recent studies have shown that immunological aberrations and epidermal barrier defects could be important in the pathogenesis of canine atopic dermatitis (CAD) and that oral polyunsaturated fatty acids (PUFAs) might influence the epidermal barrier. The aim of this study was to evaluate the effects of a spot-on formulation containing PUFAs and essential oils on pruritus and lesions caused by CAD. Forty-eight privately owned dogs of different breeds, ages and genders diagnosed with atopic dermatitis were included in a randomized, double-blinded, placebo-controlled, multicentre clinical trial. Dogs were treated with a spot-on formulation containing PUFAs and essential oils or placebo on the dorsal neck once weekly for 8weeks. Before and after the study, CAD extent and severity index-03 (CADESI-03) and pruritus scores were determined by veterinarians and owners, respectively. There was significantly more improvement in CADESI-03 and pruritus scores in the treatment group than in the placebo group (P=0.011 and P=0.036, respectively). Additionally, more dogs improved by at least 50% in CADESI-03 and pruritus scores in the treatment group than in the placebo group (P=0.008 and P=0.070, respectively). No adverse reactions were observed. The topical preparation containing PUFAs and essential oils was a safe treatment and beneficial in ameliorating the clinical signs of CAD.

Copyright © 2013 The Authors. Published by Elsevier Ltd.. All rights reserved.

KEYWORDS:

Atopic dermatitis; Canine; Essential fatty acids; Topical therapy

PMID:
24355814
[PubMed - indexed for MEDLINE]
Free full text
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Write to the Help Desk